Dexcom filed required disclosures regarding investor activity with the Securities and Exchange Commission on June 6, 2026.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dexcom filed required disclosures regarding investor activity with the Securities and Exchange Commission on June 6, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.
- Medpace filed required documents with the Securities and Exchange Commission on August 15, 2026.
- USA Rare Earth disclosed stock activity to the Securities and Exchange Commission on October 8, 2026.